StockData
HCANYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31

HCA Healthcare, Inc.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 28, 2026
$454.88−3.96 (-0.86%)

Close on Oct 19, 2026

Market cap
$103.10B
P/E (TTM)
15.6
Dividend yield
0.63%

About HCA Healthcare

Services-General Medical & Surgical Hospitals, NEC, SIC 8062

HCA Healthcare, Inc. is a healthcare services company that provides medical and outpatient care. The organization operates general acute care hospitals delivering medical and surgical specialties including cardiology, emergency medicine, oncology, neurosurgery, orthopedics, obstetrics, and intensive care. Its outpatient network encompasses freestanding ambulatory surgery centers, freestanding endoscopy and emergency care facilities, urgent care clinics, diagnostic centers, physician practices, home health agencies, and hospices. In addition, the company runs behavioral hospitals offering mental health and substance abuse treatment, along with specialized rehabilitation facilities. Its customer base consists of patients receiving care funded via private insurers, Medicare, Medicaid, managed care plans, and direct payments.

As of December 31, 2025, the company's network includes 190 hospitals, 121 freestanding ambulatory surgery centers, and 31 freestanding endoscopy centers across 19 U.S. states and England. Its principal executive offices are situated in Nashville, Tennessee.

Summary of the business section of HCA Healthcare's latest annual report, written by StockData.

Company profile

Company

Legal name
HCA Healthcare, Inc.
Founded
1968
Headquarters
Nashville, TN
Address
One Park Plz 37203
Phone
(615) 344-9551
Employees
320,000, Dec 31, 2025
Industry
Services-General Medical & Surgical Hospitals, NEC
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, Nashville, Tennessee, United States of America

Stock & identifiers

Ticker
HCA
Exchange
NYSE
Shares outstanding
217M, Jul 24, 2026
Public float
$63.27B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
860730
CUSIP
40412C101
ISIN
US40412C1018
LEI
529900PH4ZGUH2MNEU89
EIN
27-3865930

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Samuel N. HazenCEO, Director1,403,617
Michael J. SchlosserEVP and Chief Clinical Officer7,121
Michael R. McAleveyEVP & Chief Legal & Admin Off.10,990
Mike A. MarksEVP and CFO73,076
Michael S. CuffeEVP and Chief Clinical Officer35,581
Christopher F. WyattSVP & Controller44,379
Jon M. FosterEVP and COO194,516
Jennifer BerresSVP & Chief Human Res. Officer16,003
Erica RossittoSVP & Chief Nurse Executive10,825
Sammie S. MosierSVP & Chief Nurse Executive11,340
Kathleen M. WhalenSVP & Chief Ethics Officer9,454
Phillip G. BillingtonSVP-Internal Audit Services52,702
Erol R. AkdamarGroup President127,340
William R. FristDirector69,256,716
Hugh F. JohnstonDirector4,475
Nancy Ann DeparleDirector21,910
Michael W. MichelsonDirector23,385,908
John ChidseyDirector1,333
Thomas F. Frist IiiDirector68,855,888
Wayne Joseph RileyDirector15,029
Andrea B. SmithDirector4,748
Robert J. DennisDirector26,601

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Hazen
$26.46M$78.24M$8.19M$296$148
FY2024
Hazen
$23.80M$40.15M$6.12M$189$129
FY2023
Hazen
$21.32M$23.59M$6.86M$169$126
FY2022
Hazen
$14.64M$9.58M$5.17M$149$124
FY2021
Hazen
$20.64M$84.57M$6.00M$158$126
FY2020
Hazen
$30.40M$30.45M$7.04M$112$113

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“Our workforce consists of approximately 320,000 employees (as of December 31, 2025), including approximately 90,000 part-time and PRN employees (references herein to “employees” or “colleagues” refer to employees of our affiliates).”

Corporate history

Events identified from SEC filings

DateEventDetails
May 31, 2023MergerRegistration of securities for a merger or exchange offer (S-4)
May 5, 2017Name changeName changed from HCA Holdings, Inc. to HCA Healthcare, Inc.
Sep 21, 2011MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 7, 2011ListingRegistration of securities on an exchange (Form 8-A)
Nov 24, 2010Name changeName changed from HCA INC/TN to HCA Holdings, Inc.
Apr 7, 2010MergerRegistration of securities for a merger or exchange offer (S-4)
Aug 2, 2007MergerRegistration of securities for a merger or exchange offer (S-4)
Nov 24, 2006Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Nov 20, 2006DelistingNotice of delisting from exchange (Form 25)
Nov 17, 2006DeregistrationTermination of SEC registration (Form 15)
Oct 17, 2006Merger voteDefinitive merger proxy statement
Mar 11, 2004ListingRegistration of securities on an exchange (Form 8-A)
May 21, 2001Name changeName changed from HCA THE HEALTHCARE CO to HCA INC/TN
May 19, 2000Name changeName changed from COLUMBIA HCA HEALTHCARE CORP to HCA-THE HEALTHCARE CO
Aug 9, 1999MergerRegistration of securities for a merger or exchange offer (S-4)
Feb 6, 1997MergerRegistration of securities for a merger or exchange offer (S-4)
Feb 12, 1996DeregistrationTermination of SEC registration (Form 15)
Jul 17, 1995DeregistrationTermination of SEC registration (Form 15)
Apr 28, 1995MergerRegistration of securities for a merger or exchange offer (S-4)
Dec 9, 1994MergerRegistration of securities for a merger or exchange offer (S-4)
Jul 7, 1994MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 1, 1994Name changeName changed from COLUMBIA HEALTHCARE CORP to COLUMBIA HCA HEALTHCARE CORP/